Pediatric Oncology: Managing Pain at the End of Life.
- Published in:
- Pediatric Drugs, 2016, v. 18, n. 3, p. 161, doi. 10.1007/s40272-016-0168-2
- By:
- Publication type:
- Article
Works matching IS 11745878 AND DT 2016 AND VI 18 AND IP 3
Results: 8
1
2
Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus.
- Published in:
- Pediatric Drugs, 2016, v. 18, n. 3, p. 181, doi. 10.1007/s40272-016-0170-8
- By:
- Publication type:
- Article
3
Pharmacotherapy for Dravet Syndrome.
- Published in:
- Pediatric Drugs, 2016, v. 18, n. 3, p. 197, doi. 10.1007/s40272-016-0171-7
- By:
- Publication type:
- Article
4
Infantile Periocular Haemangioma: Optimising the Therapeutic Response.
- Published in:
- Pediatric Drugs, 2016, v. 18, n. 3, p. 157, doi. 10.1007/s40272-016-0172-6
- By:
- Publication type:
- Article
5
Product Substitution as a Way Forward in Avoiding Potentially Harmful Excipients in Neonates.
- Published in:
- Pediatric Drugs, 2016, v. 18, n. 3, p. 221, doi. 10.1007/s40272-016-0173-5
- By:
- Publication type:
- Article
6
Pediatric Glaucoma: Pharmacotherapeutic Options.
- Published in:
- Pediatric Drugs, 2016, v. 18, n. 3, p. 209, doi. 10.1007/s40272-016-0174-4
- By:
- Publication type:
- Article
7
Substitution as a Strategy to Improve Excipient Exposure in Neonates: One Piece of the Puzzle.
- Published in:
- Pediatric Drugs, 2016, v. 18, n. 3, p. 231, doi. 10.1007/s40272-016-0178-0
- By:
- Publication type:
- Article
8
Late Post-traumatic Epilepsy in Children and Young Adults: Impropriety of Long-Term Antiepileptic Prophylaxis and Risks in Tapering.
- Published in:
- Pediatric Drugs, 2016, v. 18, n. 3, p. 235, doi. 10.1007/s40272-016-0167-3
- By:
- Publication type:
- Article